Cardinal Health, Inc. (NYSE:CAH) has been a topic of considerable discussion and analysis. With
84% institutionally owned, it has seen its
stock rise nearly 7% this year. There have been
additions to the board of directors, and Cardinal Health has announced
two strategic additions to its portfolio. Furthermore, it has updated its
Fiscal Year 2025 earnings expectations and raised its
quarterly dividend. Acquisitions also feature prominently, with the purchase of the
Integrated Oncology Network and their plans to open a new distribution center in
Fort Worth, Texas. Throughout all this, the value of Cardinal Health stock has fluctuated but has generally exceeded market gains. Its stock performance and growth potential under new management scored it a
'buy' rating, driven by strong earnings and strategic acquisitions. Evercore ISI and BofA have lifted their ratings on CAH, expecting upside to their EPS estimates.
Cardinal Health CAH News Analytics from Fri, 09 Aug 2024 07:00:00 GMT to Fri, 14 Mar 2025 13:00:22 GMT -
Rating 4
- Innovation 2
- Information 8
- Rumor -6
